LogicBio Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 39
Employees
  • Stock Symbol
  • LOGC
Stock Symbol
  • Share Price
  • $1.95
  • (As of Friday Closing)

LogicBio Therapeutics General Information

Description

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 610 Main Street
  • 3rd Floor
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LogicBio Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.95 $1.97 $1.83 - $9.74 $64.3M 33M 96.4K -$1.15

LogicBio Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 94,928 226,542 112,322 250,817
Revenue 3,925 3,454 0 0
EBITDA (36,043) (31,041) (40,771) (18,013)
Net Income (37,866) (32,621) (40,128) (17,621)
Total Assets 68,186 80,640 55,660 82,910
Total Debt 14,320 16,065 10,314 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

LogicBio Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial

LogicBio Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial

LogicBio Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in
Biotechnology
Cambridge, MA
39 As of 2020
00000
0000 0000-00-00
00000000 00000

000000 0

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

00000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LogicBio Therapeutics Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CRISPR Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 000000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
000 00000000000 Corporation La Jolla, CA 0000000000
00000 Corporation New York, NY 0 00000 000000000 00000
You’re viewing 5 of 67 competitors. Get the full list »

LogicBio Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Frederic Chereau Chief Executive Officer & Board Member
Cecilia Jones Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Kyle Chiang Ph.D Chief Operating Officer
Mariana Nacht Chief Scientific Officer
Adi Barzel Ph.D Co-Founder
You’re viewing 5 of 10 executive team members. Get the full list »

LogicBio Therapeutics Board Members (11)

Name Representing Role Since
Daphne Karydas Self Board Member 000 0000
Erez Chimovits LogicBio Therapeutics Board Member 000 0000
Frederic Chereau LogicBio Therapeutics Chief Executive Officer & Board Member 000 0000
Leon Chen Ph.D OrbiMed Board Member 000 0000
Leszek Lisowski LogicBio Therapeutics Co-Founder & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

LogicBio Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LogicBio Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial